Get the up-to-date EuroNet-Paediatric Hodgkins Lymphoma Group - skion 2023 now

Get Form
Form preview image

Here's how it works

01. Edit your form online
01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
03. Share your form with others
Send it via email, link, or fax. You can also download it, export it or print it out.

The best way to change EuroNet-Paediatric Hodgkins Lymphoma Group - skion online

Form edit decoration
Ease of Setup
DocHub User Ratings on G2
Ease of Use
DocHub User Ratings on G2

With DocHub, making changes to your paperwork takes just a few simple clicks. Make these quick steps to change the PDF EuroNet-Paediatric Hodgkins Lymphoma Group - skion online for free:

  1. Sign up and log in to your account. Sign in to the editor with your credentials or click Create free account to evaluate the tool’s features.
  2. Add the EuroNet-Paediatric Hodgkins Lymphoma Group - skion for editing. Click on the New Document button above, then drag and drop the file to the upload area, import it from the cloud, or via a link.
  3. Alter your file. Make any changes needed: add text and pictures to your EuroNet-Paediatric Hodgkins Lymphoma Group - skion, highlight details that matter, remove parts of content and replace them with new ones, and insert symbols, checkmarks, and areas for filling out.
  4. Complete redacting the template. Save the modified document on your device, export it to the cloud, print it right from the editor, or share it with all the parties involved.

Our editor is very intuitive and effective. Give it a try now!

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
Positron emission tomography (PET)\u2013adapted chemotherapy and radiotherapy approaches are currently used for the initial treatment of early-stage Hodgkin lymphoma (HL) with progression-free survival and overall survival exceeding 85% and 95%, respectively.
The 5-year survival rate tells you what percent of children and teens live at least 5 years after the cancer is found. Percent means how many out of 100. In general, the 5-year survival rate for children ages 0 to 14 with NHL is 91%. The 5-year survival rate for teens ages 15 to 19 is 89%.
Risk factors for childhood Hodgkin lymphoma include the following: Being infected with the Epstein-Barr virus (EBV). Being infected with the human immunodeficiency virus (HIV). Having certain diseases of the immune system, such as autoimmune lymphoproliferative syndrome.
Five-year survival for Hodgkin lymphoma is highest in the youngest men and women and decreases with increasing age. Five-year net survival in men ranges from 95% in 15-39 year-olds to 23% in 80-99 year-olds for patients diagnosed with Hodgkin lymphoma in England during 2009-2013.
Nodular sclerosing Hodgkin lymphoma has a higher survival rate than other types of classic Hodgkin lymphoma, with the five-year survival rate being greater than 90%.
be ready to get more

Complete this form in 5 minutes or less

Get form

People also ask

Hodgkin lymphoma is considered one of the most treatable cancers, with more than 90 percent of patients surviving more than five years.
Todays FDA approval of brentuximab vedotin () in combination with chemotherapy to treat Stage 3 and Stage 4 HL patients who are newly diagnosed and have received no prior treatment, is docHub for a patient population that has seen no change in the standard of care in more than four decades.
Approximately 90% to 95% of children with Hodgkin lymphoma can be cured, prompting increased attention to therapy that lessens long-term morbidity for these patients.
Most children who are treated for lymphoma recover well with few long-term effects. However, because they have had cancer treatment, they have a higher risk of developing certain health problems in later life than people who have not been treated for cancer. These are called late effects.
Chemotherapy drugs used for Hodgkin lymphoma The most common combination used to treat HL is called ABVD. This chemotherapy is given every 2 weeks for 2 to 8 months, depending on the stage and response to treatment. ABVD includes , , vinblastine and .

Related links